Physician profile

Vishal Bhatia

Endocrinology, Diabetes & Metabolism · Evansville, IN

NPI 1467653402

$1,264.62

in general payments reported to CMS, 2019-2025

20 companies · $105 in 2025

The $105 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).

See the full distribution for Endocrinology, Diabetes & Metabolism

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$213.32
Education$14.52

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Amgen INC. $432.02 2019-2020
Alexion Pharmaceuticals, INC. $173.85 2019
Inari Medical, INC. $83.63 2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Novo Nordisk INC $77.85 2019
Lilly USA, LLC $69.76 2019
Stryker Corporation $65.56 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Mannkind Corporation $59.40 2021
Sanofi-Aventis U.S. LLC $54.66 2019
Radius Health, INC. $45.21 2019-2023
Medtronic, INC. $39.60 2025 Minimed 780g
Antares Pharma, INC. $26.47 2019
Insulet Corporation $24.53 2024 Omnipod
Beckman Coulter, INC. $20.26 2021
Regeneron Healthcare Solutions, INC. $18.74 2019
Shire North American Group INC $15.61 2019
Show all 20 companies
CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $14.95 2019
Celgene Corporation $11.40 2019
Boehringer Ingelheim Pharmaceuticals, INC. $10.87 2019
Dexcom, INC. $10.25 2019
Senseonics, Incorporated $10.00 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Vishal Bhatia

$1,264.62

in general payments reported 2019-2025

Years
2019-2025
Top company
Amgen INC.
Context
The $105 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).

https://glasscript.com/doctor/1230580/vishal-bhatia

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.